CYSTIC FIBROSIS

Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents

T L Pitt, M Sparrow, M Warner, M Stefanidou

Laboratory of HealthCare Associated Infection, Specialist and Reference Microbiology Division, Health Protection Agency, London NW9 5HT, UK

Correspondence to:
Correspondence to:
Dr T L Pitt, Laboratory of HealthCare Associated Infection, Specialist and Reference Microbiology Division, Health Protection Agency, 61 Colindale Avenue, London NW9 5HT, UK;
Tyrone.Pitt{at}HPA.org.uk

Background: Respiratory infection with Pseudomonas aeruginosa is very common in patients with cystic fibrosis (CF) but antimicrobial resistance rates of CF isolates across the UK are largely unknown.

Methods: The susceptibility of 417 CF patient isolates of P aeruginosa from 17 hospitals to six commonly prescribed antibiotics were examined. Isolates were tested by an agar break point dilution method and E-tests according to British Society of Antimicrobial Chemotherapy guidelines. Genotyping of isolates was performed by XbaI DNA macrorestriction and pulsed field gel electrophoresis.

Results: 38% of isolates were susceptible to all of the agents tested; almost half were resistant to gentamicin compared with ceftazidime (39%), piperacillin (32%), ciprofloxacin (30%), tobramycin (10%), and colistin (3%). Approximately 40% were resistant to two or more compounds with ceftazidime in combination with gentamicin, piperacillin or ciprofloxacin being the most common cross resistances. Resistance rates were generally similar to those reported recently from the USA and Germany. A selection of resistant isolates proved to be predominantly genotypically distinct by XbaI DNA macrorestriction but six pairs from three centres had similar genotypes.

Conclusions: The level of resistance to front line antipseudomonal agents, with the exception of colistin, is disturbingly high. The prudent use of antimicrobial drugs and closer monitoring of accumulation of resistant strain populations should be actively considered.

Keywords: cystic fibrosis; Pseudomonas aeruginosa; antimicrobial resistance

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Foweraker, J. E., Laughton, C. R., Brown, D. F., Bilton, D. (2009). Comparison of Methods To Test Antibiotic Combinations against Heterogeneous Populations of Multiresistant Pseudomonas aeruginosa from Patients with Acute Infective Exacerbations in Cystic Fibrosis. Antimicrob. Agents Chemother. 53: 4809-4815 [Abstract] [Full Text]  
• Hubert, D., Le Roux, E., Lavrut, T., Wallaert, B., Scheid, P., Manach, D., Grenet, D., Sermet-Gaudelus, I., Ramel, S., Cracowski, C., Sardet, A., Wizla, N., Deneuville, E., Garraffo, R. (2009). Continuous versus Intermittent Infusions of Ceftazidime for Treating Exacerbation of Cystic Fibrosis. Antimicrob. Agents Chemother. 53: 3650-3656 [Abstract] [Full Text]  
• El Solh, A. A., Alhajhusain, A. (2009). Update on the treatment of Pseudomonas aeruginosa pneumonia. J Antimicrob Chemother 64: 229-238 [Abstract] [Full Text]  
• Sun, S., Negrea, A., Rhen, M., Andersson, D. I. (2009). Genetic Analysis of Colistin Resistance in Salmonella enterica Serovar Typhimurium. Antimicrob. Agents Chemother. 53: 2298-2305 [Abstract] [Full Text]  
• Strateva, T., Petrova, G., Perenovska, P., Mitov, I. (2009). Bulgarian cystic fibrosis Pseudomonas aeruginosa isolates: antimicrobial susceptibility and neuraminidase-encoding gene distribution. J Med Microbiol 58: 690-692 [Full Text]  
• Foweraker, J. (2009). Recent advances in the microbiology of respiratory tract infection in cystic fibrosis. Br Med Bull 89: 93-110 [Abstract] [Full Text]  
• Smyth, A, Lewis, S, Bertenshaw, C, Choonara, I, McGaw, J, Watson, A (2008). Case-control study of acute renal failure in patients with cystic fibrosis in the UK. Thorax 63: 532-535 [Abstract] [Full Text]  
• Smyth, A, Elborn, J S (2008). Exacerbations in cystic fibrosis: 3 {middle dot} Management. Thorax 63: 180-184 [Abstract] [Full Text]  
• Deslouches, B., Gonzalez, I. A., DeAlmeida, D., Islam, K., Steele, C., Montelaro, R. C., Mietzner, T. A. (2007). De novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia. J Antimicrob Chemother 60: 669-672 [Abstract] [Full Text]  
• Bulitta, J. B., Duffull, S. B., Kinzig-Schippers, M., Holzgrabe, U., Stephan, U., Drusano, G. L., Sorgel, F. (2007). Systematic Comparison of the Population Pharmacokinetics and Pharmacodynamics of Piperacillin in Cystic Fibrosis Patients and Healthy Volunteers. Antimicrob. Agents Chemother. 51: 2497-2507 [Abstract] [Full Text]  
• Bertenshaw, C., Watson, A. R, Lewis, S., Smyth, A. (2007). Survey of acute renal failure in patients with cystic fibrosis in the UK. Thorax 62: 541-545 [Abstract] [Full Text]  
• Ratjen, F., Rietschel, E., Kasel, D., Schwiertz, R., Starke, K., Beier, H., van Koningsbruggen, S., Grasemann, H. (2006). Pharmacokinetics of inhaled colistin in patients with cystic fibrosis. J Antimicrob Chemother 57: 306-311 [Abstract] [Full Text]  
• Deslouches, B., Islam, K., Craigo, J. K., Paranjape, S. M., Montelaro, R. C., Mietzner, T. A. (2005). Activity of the De Novo Engineered Antimicrobial Peptide WLBU2 against Pseudomonas aeruginosa in Human Serum and Whole Blood: Implications for Systemic Applications. Antimicrob. Agents Chemother. 49: 3208-3216 [Abstract] [Full Text]  
• Poole, K. (2005). Aminoglycoside Resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49: 479-487 [Full Text]  
• Kugelberg, E., Lofmark, S., Wretlind, B., Andersson, D. I. (2005). Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa. J Antimicrob Chemother 55: 22-30 [Abstract] [Full Text]  
• Hogardt, M., Schmoldt, S., Gotzfried, M., Adler, K., Heesemann, J. (2004). Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients. J Antimicrob Chemother 54: 1057-1061 [Abstract] [Full Text]  
• O'Carroll, M.R., Syrmis, M.W., Wainwright, C.E., Greer, R.M., Mitchell, P., Coulter, C., Sloots, T.P., Nissen, M.D., Bell, S.C. (2004). Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units. Eur Respir J 24: 101-106 [Abstract] [Full Text]